As of March 23, 2026, Ocular Therapeutix's top three insider holders are Road Llc Summer (TenPercentOwner, 8.59Mn shares), Pravin Dugel (See Remarks, 3.01Mn shares), Antony C. Mattessich (President And Ceo, 588.70K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Road Llc Summer | 0 | 8,591,401 | 27 Feb, 2024 | |
| Pravin Dugel | See Remarks | 3,013,022 | 0 | 25 Feb, 2026 |
| Antony C. Mattessich | President And Ceo | 588,701 | 0 | 06 Feb, 2024 |
| Donald Notman | Chief Operating Officer | 366,356 | 0 | 17 Feb, 2026 |
| Sanjay Nayak | Chief Strategy Officer | 330,653 | 0 | 25 Feb, 2026 |
| Jeffrey S. Heier | Chief Scientific Officer | 323,368 | 0 | 25 Feb, 2026 |
| Nadia Waheed | Chief Medical Officer | 314,907 | 0 | 24 Feb, 2026 |
| Michael H. Goldstein | President, Ophthalmology Cmo | 313,335 | 0 | 07 Feb, 2022 |
| Pravin Dugel | See Remarks | 0 | 300,115 | 26 Nov, 2025 |
| Peter Kaiser | Chief Development Officer | 269,108 | 0 | 25 Feb, 2026 |
| Namrata Saroj | Chief Business Officer | 254,620 | 0 | 06 Jan, 2026 |
| Steve Lawrence Meyers | Chief Commercial Officer | 217,628 | 0 | 06 Jan, 2026 |
| Philip C. Strassburger | General Counsel | 161,493 | 0 | 06 Feb, 2024 |
| Rabia Gurses Ozden | Chief Medical Officer | 153,054 | 0 | 06 Feb, 2024 |
| Todd Anderman | Chief Legal Officer | 152,468 | 0 | 06 Jan, 2026 |
| David Wayne Robinson | Global Cco | 136,000 | 0 | 26 Jan, 2026 |
| Christopher G White | Chief Business Officer | 123,689 | 0 | 06 Feb, 2024 |
| Charles M Warden | 86,464 | 0 | 13 Jun, 2025 | |
| Leslie J. Williams | 51,433 | 0 | 13 Jun, 2025 | |
| Adrienne L Graves | 50,000 | 0 | 13 Jun, 2025 | |
| Seung Suh Hong | 46,933 | 0 | 13 Jun, 2025 | |
| Merilee Raines | 46,933 | 0 | 13 Jun, 2025 | |
| Antony C. Mattessich | President And Ceo | 0 | 6,500 | 05 Sep, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Feb, 2026 | Pravin Dugel | Common Stock | D | 20,056 | $8.28 | 3,013,022 | D | S |
| 23 Feb, 2026 | Jeffrey S. Heier | Common Stock | D | 3,057 | $8.28 | 323,368 | D | S |
| 23 Feb, 2026 | Peter Kaiser | Common Stock | D | 2,810 | $8.28 | 269,108 | D | S |
| 23 Feb, 2026 | Sanjay Nayak | Common Stock | D | 1,759 | $8.28 | 330,653 | D | S |
| 20 Feb, 2026 | Nadia Waheed | Common Stock | D | 3,510 | $7.74 | 314,907 | D | S |
| 12 Feb, 2026 | Donald Notman | Common Stock | D | 11,446 | $9.04 | 366,356 | D | S |
| 12 Feb, 2026 | Nadia Waheed | Common Stock | D | 7,863 | $9.04 | 318,417 | D | S |
| 12 Feb, 2026 | Sanjay Nayak | Common Stock | D | 10,348 | $9.04 | 332,412 | D | S |
| 12 Feb, 2026 | Pravin Dugel | Common Stock | D | 124,882 | $9.04 | 3,033,078 | D | S |
| 02 Feb, 2026 | Donald Notman | Common Stock | D | 5,455 | $9.14 | 383,837 | D | S |
| 04 Feb, 2026 | Donald Notman | Common Stock | D | 6,035 | $8.54 | 377,802 | D | S |
| 21 Jan, 2026 | David Wayne Robinson | Common Stock | A | 136,000 | $0.00 | 136,000 | D | A |
| 21 Jan, 2026 | David Wayne Robinson | Stock Option (Right to Buy) | A | 416,000 | $0.00 | 416,000 | D | A |
| 20 Jan, 2026 | Jason Shand Robins | Stock Option (Right to Buy) | A | 33,000 | $0.00 | 33,000 | D | A |
| 02 Jan, 2026 | Nadia Waheed | Common Stock | A | 79,112 | $0.00 | 326,280 | D | A |
| 02 Jan, 2026 | Donald Notman | Common Stock | A | 79,112 | $0.00 | 389,292 | D | A |
| 02 Jan, 2026 | Jeffrey S. Heier | Common Stock | A | 79,112 | $0.00 | 326,425 | D | A |
| 02 Jan, 2026 | Namrata Saroj | Common Stock | A | 79,112 | $0.00 | 254,620 | D | A |
| 02 Jan, 2026 | Steve Lawrence Meyers | Common Stock | A | 64,900 | $0.00 | 217,628 | D | A |
| 02 Jan, 2026 | Todd Anderman | Common Stock | A | 64,900 | $0.00 | 152,468 | D | A |